EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Drug-related problems among hospitalized patients with cardiovascular diseases in China: a retrospective study

Xinan Wu, Deying Xu, Qian Wang, Shanshan Gao, Xueyuan Hou, Lingling Huang, Feifei Wang

Frontiers in Cardiovascular Medicine · 05.11.2026 · 13

DOI: 10.3389/fcvm.2026.1970846 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Cardiovascular Medicine, online erschienen am 05.11.2026. Verfasst von Xinan Wu und 6 weiteren Autor:innen. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Data are lacking on the baseline characteristics of drug-related problems (DRPs) and the impact of clinical pharmacy activities among patients with cardiovascular diseases (CVDs) in China. This study aimed to characterize the features of DRPs in patients with CVDs and to identify factors associated with the presence of multiple DRPs.

Methods

A retrospective study was conducted among hospitalized patients with CVDs at a tertiary hospital in China from July 2022 to February 2024. During the study period, clinical pharmacists reviewed medication orders, documented DRPs and interventions, and classified DRPs according to the Pharmaceutical Care Network Europe (PCNE) Classification version 9.1. Baseline characteristics were evaluated, and patients were stratified into two groups based on the number of DRPs: those with a single DRP and those with multiple DRPs. Multivariable logistic regression analysis was performed to identify factors associated with the presence of multiple DRPs.

Results

In total, 312 interventions associated with DRPs were recorded for 213 hospitalized patients with CVDs, and 30.52% of the patients with at least one DRP experienced multiple DRPs. The most frequent category of DRPs was “treatment effectiveness (P1)”, whereas the most common cause was “drug selection (C1)”. The most common intervention was “drug started (I3.6)”. Of all recommendations made, 75.00% were accepted and implemented (A1.1) and a further 13.14% were accepted but not implemented (A1.3), yielding an overall acceptance rate of 88.14% (A1). Multivariable analysis revealed that eGFR < 45 mL/min/1.73 m² (OR = 2.280, 95% CI: 1.035-5.020, P = 0.041) and hospital stay 7 days (OR = 2.615, 95% CI: 1.148-5.955, P =0.022) were significantly associated with the presence of multiple DRPs.

Conclusion

Clinical pharmacists identified a considerable number of guideline-discordant medication decisions in hospitalized patients with CVDs, and prescribers accepted most of the resulting recommendations.

Zitieren

APA

Wu, X., Xu, D., Wang, Q., Gao, S., Hou, X., Huang, L., & Wang, F. (2026). Drug-related problems among hospitalized patients with cardiovascular diseases in China: a retrospective study. Frontiers in Cardiovascular Medicine, 13. https://doi.org/10.3389/fcvm.2026.1970846

Vancouver

Wu X, Xu D, Wang Q, Gao S, Hou X, Huang L, et al. Drug-related problems among hospitalized patients with cardiovascular diseases in China: a retrospective study. Frontiers in Cardiovascular Medicine. 2026;13. doi:10.3389/fcvm.2026.1970846

BibTeX
@article{Wu2026,
  author = {Wu, Xinan and Xu, Deying and Wang, Qian and Gao, Shanshan and Hou, Xueyuan and Huang, Lingling and Wang, Feifei},
  title = {Drug-related problems among hospitalized patients with cardiovascular diseases in China: a retrospective study},
  journal = {Frontiers in Cardiovascular Medicine},
  year = {2026},
  volume = {13},
  doi = {10.3389/fcvm.2026.1970846}
}
Kostenlos starten →